Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

UT Southwestern Chair of Molecular Biology Wins 2012 Beering Award

Published: Tuesday, April 03, 2012
Last Updated: Tuesday, April 03, 2012
Bookmark and Share
Dr. Eric N. Olson wins Beering Award for outstanding advancements in biomedical or clinical science.

Dr. Eric N. Olson, chairman of molecular biology at UT Southwestern Medical Center, is the winner of the 2012 Steven C. Beering Award for outstanding advancements in biomedical or clinical science.

Dr. Olson is known for his work at the interface of developmental biology and medicine that identified major genetic pathways controlling the formation of the heart and other muscles. Several drugs based on his research are currently under study.

The award is given annually by the Indiana University School of Medicine.

At UT Southwestern, Dr. Olson directs the Nancy B. and Jake L. Hamon Center for Basic Research in Cancer and the Nearburg Family Center for Basic and Clinical Research in Pediatric Oncology.

A member of the National Academy of Sciences and the Institute of Medicine, Dr. Olson will present a lecture to medical students, graduate students, postdoctoral researchers and medical residents on the Indianapolis campus Oct. 16, followed by the Beering Award lecture on Oct. 17. The award includes a medal and a $25,000 prize.

Several Beering awardees have gone on to win the Nobel Prize. 1990 Beering winner Dr. Alfred G. Gilman, UT Southwestern professor emeritus of pharmacology and chief scientific officer for the Cancer Prevention and Research Institute of Texas, was awarded a Nobel in 1994.

The Passano Foundation recently named Dr. Olson the winner of the 2012 Passano Award, a $50,000 prize created in 1943 to honor U.S.-based research that leads to real-world applications.

Dr. Olson will accept that prize April 30 in Baltimore. Twenty-three Passano Award recipients have gone on to win the Nobel Prize including Dr. Gilman, Dr. Joseph L. Goldstein, chairman of molecular genetics; and his 1985 co-winner Dr. Michael S. Brown, director of the Erik Jonsson Center for Research in Molecular Genetics and Human Disease.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rapid Bone Loss Possible Side Effect of Anti-Obesity Drug
Research from UT Southwestern Medical Center has raised concern about the safe use of fibroblast growth factor 21.
Tuesday, February 07, 2012
Circuit Regulating Anti-Diabetic Actions of Serotonin Uncovered By UT Southwestern Researchers
A brain chemical known to help regulate emotion, mood and sleep – might also have anti-diabetic properties, findings suggest.
Friday, November 12, 2010
Brain Chemical Boosts Body Heat and Aids in Calorie Burn, Suggests Recent UT Southwestern Research
Newly found enzyme in the brain might control the increased generation of body heat that helps burn off excess calories after eating high-fat meals.
Thursday, July 08, 2010
Experimental Drug Shows Promise Against Brain, Prostate Cancers, UT Southwestern Researchers Find
Study shows that drug attacked not only the bulk of the tumor cells but also the rare cancer stem cells responsible for cancer’s growth.
Wednesday, January 06, 2010
Anemia Drug Not Helpful for Kidney Disease Patients, UT Southwestern Researcher Reports
Study concluds that the anemia drug darbepoetin alfa works no better than a placebo in several applications previously thought to be promising.
Thursday, December 24, 2009
Tiny Molecule Slows Progression of Lou Gehrig’s Disease in Mice, UT Southwestern Researchers Find
A molecule produced naturally by muscles in response to nerve damage can reduce symptoms and prolong life in ALS mouse model.
Tuesday, December 15, 2009
UT Southwestern Researchers Use Drug-Radiation Combo to Eradicate Lung Cancer
Researchers have eliminated non-small cell lung cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.
Friday, November 06, 2009
UT Southwestern Researchers Examine Mechanisms that Help Cancer Cells Proliferate
A process that limits the number of times a cell divides works much differently than had been thought, say researchers.
Thursday, September 03, 2009
Higher Drug Doses Needed to Defeat Tuberculosis, UT Southwestern Researchers Report
The typical dose of a medication considered pivotal in treating tuberculosis effectively is much too low to account for modern-day physiques, researchers say.
Monday, August 03, 2009
UT Southwestern Earns Grant from American Heart Association for Cardiac Myogenesis Research Center
The $2 million grant will help to study the development and mechanisms of generating new cardiac muscle cells.
Thursday, July 23, 2009
UT Southwestern Research Reveals How Cells Tell Time
In a new study researchers have found a mold that uses FRQ protein to mark time by a sequence of changes in the protein’s chemical structure.
Wednesday, June 10, 2009
UT Southwestern Researchers Probe Kidney Damage, Protection in Lupus
Researchers also found that a certain set of genes appears to protect the kidneys from a different sort of immune attack.
Monday, April 27, 2009
UT Southwestern Researchers Find Marker for Severity in Adult Brain Cancer
Researchers have identified a new biological indicator that may help identify which brain-cancer patients have the most aggressive forms of the disease.
Thursday, April 16, 2009
UT Southwestern Researchers Disrupt Biochemical System Involved in Cancer, Degenerative Disease
Researchers identify two new chemical compounds that can be used to study and manipulate a cellular pathway involved in cancer and degenerative diseases.
Monday, February 02, 2009
Natural Brain Substance Blocks Weight Gain in Mice, UT Southwestern Researchers Discover
The chemical, orexin, works by increasing the body’s sensitivity to the weight-loss hormone, the researchers report.
Thursday, January 29, 2009
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos